


What’s New in SLE: Pathogenesis & Novel Therapies

Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Difficult-to-Treat Lupus: When & How to Use New Therapies

Never Too Late: Late-Breaking Abstracts Create Excitement

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus
HCQ/CQ May Increase the Risk of Cardiovascular Events

Using the 2019 EULAR/ACR Classification Criteria to Predict Disease Severity in SLE

How Pediatric Rheumatologists Are Moving Lupus Research Forward

Updates in Pediatric Lupus: Experts Discuss Advances in Lupus Nephritis Treatments, Monogenic Lupus & More
- 1
- 2
- 3
- …
- 11
- Next Page »